These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12549)

  • 1. Changes in brain catecholamines and spontaneous locomotor activity in response to thyrotropin releasing hormone.
    Agarwal RA; Rastogi RB; Singhal RL
    Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):743-52. PubMed ID: 12549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of neonatal and adult hyperthyroidism on behavior and biosynthetic capacity for norepinephrine, dopamine and 5-hydroxytryptamine in rat brain.
    Rastogi RB; Singhal RL
    J Pharmacol Exp Ther; 1976 Sep; 198(3):609-18. PubMed ID: 978462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MK-771 enhances the turnover of norepinephrine in brain.
    Rastogi RB; Singhal RL
    Res Commun Chem Pathol Pharmacol; 1981 Jul; 33(1):187-90. PubMed ID: 6115460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium: modification of behavioral activity and brain biogenic amines in developing hyperthyroid rats.
    Rastoge RB; Singhal RL
    J Pharmacol Exp Ther; 1977 Apr; 201(1):92-102. PubMed ID: 850149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated exposure of adult rats to Aroclor 1254 causes brain region-specific changes in intracellular Ca2+ buffering and protein kinase C activity in the absence of changes in tyrosine hydroxylase.
    Kodavanti PR; Derr-Yellin EC; Mundy WR; Shafer TJ; Herr DW; Barone S; Choksi NY; MacPhail RC; Tilson HA
    Toxicol Appl Pharmacol; 1998 Dec; 153(2):186-98. PubMed ID: 9878590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Involvement of tyrosine hydroxylase in functional characteristics of discrete brain nuclei].
    Nakahara T; Uchimura H; Hirano M
    Yakubutsu Seishin Kodo; 1987 Dec; 7(4):453-61. PubMed ID: 2898187
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings: Thyrotropin-releasing hormone: activation of cerebral noradrenaline turnover.
    Keller HH; Bartholini G
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R46. PubMed ID: 4276583
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancement of locomotor activity and catecholamine and 5-hydroxytryptamine metabolism by thyrotropin releasing hormone.
    Agarwal RA; Rastogi RB; Singhal RL
    Neuroendocrinology; 1977; 23(4):236-47. PubMed ID: 409963
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of repeated treatment with high doses of selegiline on behaviour, striatal dopaminergic transmission and tyrosine hydroxylase mRNA levels.
    Themann C; Alvarez Fischer D; Gross S; Westermann R; Weihe E; Kuschinsky K; Schäfer H; Ferger B
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan; 365(1):22-8. PubMed ID: 11862330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of thyrotropin-releasing hormone on the locomotor and sensitizing effects of cocaine in rats.
    Przegaliński E; Papla I; Czepiel K; Wydra K; Nowak E; Lasoń W; Filip M
    Neuropeptides; 2004 Feb; 38(1):48-54. PubMed ID: 15003716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral effects of hypothalamic releasing hormones in animals and men.
    Prange AJ; Wilson IC; Breese GR; Lipton MA
    Prog Brain Res; 1975; 42():1-9. PubMed ID: 729
    [No Abstract]   [Full Text] [Related]  

  • 12. Thyrotropin-releasing hormone--increased catabolism of catecholamines in brains of thyroidectomized rats.
    Marek K; Haubrich DR
    Biochem Pharmacol; 1977 Oct; 26(19):1817-8. PubMed ID: 410420
    [No Abstract]   [Full Text] [Related]  

  • 13. Thyrotropin releasing hormone: neurochemical evidence for the potentiation of imipramine effects on the metabolism and uptake of brain catecholamines.
    Rastogi RB; Singhal RL; Lapierre YD
    Psychopharmacology (Berl); 1980; 72(1):85-91. PubMed ID: 6110219
    [No Abstract]   [Full Text] [Related]  

  • 14. A developmental role for catecholamines in Drosophila behavior.
    Pendleton RG; Rasheed A; Paluru P; Joyner J; Jerome N; Meyers RD; Hillman R
    Pharmacol Biochem Behav; 2005 Aug; 81(4):849-53. PubMed ID: 16051344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of behavioral tolerance by repeated treatment with taltirelin hydrate, a thyrotropin-releasing hormone analog, in rats.
    Asai H; Asahi T; Yamamura M; Yamauchi-Kohno R; Saito A
    Pharmacol Biochem Behav; 2005 Dec; 82(4):646-51. PubMed ID: 16368129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of effect of chronically administered thyrotropin-releasing hormone (TRH) on regional rat brain tyrosine hydroxylase activity.
    Nemeroff CB; Diez JA; Bissette G; Prange AJ; Harrell LE; Lipton MA
    Pharmacol Biochem Behav; 1977 Apr; 6(4):467-9. PubMed ID: 18744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics of the neuromodulating effect of peripherally administered thyroliberin on the rat brain].
    Misin'sh IP; Klusha VE
    Biull Eksp Biol Med; 1986 Jan; 101(1):50-2. PubMed ID: 3080036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIF prolyl hydroxylase inhibition augments dopamine release in the rat brain in vivo.
    Witten L; Sager T; Thirstrup K; Johansen JL; Larsen DB; Montezinho LP; Mørk A
    J Neurosci Res; 2009 May; 87(7):1686-94. PubMed ID: 19156859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of inhibitors of the catecholamine synthesis on motor activity in the rat during light and darkness.
    Berger T; Lemmer B
    Pol J Pharmacol Pharm; 1976; 28(6):601-3. PubMed ID: 1012983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Noradrenaline metabolism in the brain of rolling mouse Nagoya and the influence of thyrotropin releasing hormone (author's transl)].
    Konagaya M; Takayanagi T; Muroga T; Adachi K; Sobue I
    Rinsho Shinkeigaku; 1980 Mar; 20(3):181-8. PubMed ID: 6103773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.